NASDAQ
EBACW

European Biotech Acquisition Corp

Prices are adjusted according to historical splits.

European Biotech Acquisition Corp Stock Price

Vitals

Today's Low:
$0.5
Today's High:
$0.5499
Open Price:
$0.5499
52W Low:
$0.02
52W High:
$0.7355
Prev. Close:
$0.55
Volume:
18331

Company Statistics

Market Cap.:
$0
Book Value:
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
0%
Return on Equity TTM:
0%

Company Profile

European Biotech Acquisition Corp had its IPO on 2021-05-13 under the ticker symbol EBACW.

The company operates in the sector and industry. European Biotech Acquisition Corp has a staff strength of 0 employees.

Stock update

Shares of European Biotech Acquisition Corp opened at $0.55 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.5 - $0.55, and closed at $0.52.

This is a -6.36% slip from the previous day's closing price.

A total volume of 18,331 shares were traded at the close of the day’s session.

In the last one week, shares of European Biotech Acquisition Corp have increased by +11.38%.

European Biotech Acquisition Corp's Key Ratios

European Biotech Acquisition Corp has a market cap of $0, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months European Biotech Acquisition Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures European Biotech Acquisition Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, European Biotech Acquisition Corp’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q4, European Biotech Acquisition Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

European Biotech Acquisition Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into European Biotech Acquisition Corp’s profitability.

European Biotech Acquisition Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

European Biotech Acquisition Corp stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$129.75 million
Total Liabilities
$795568.00
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

European Biotech Acquisition Corp ended 2024 with $129.75 million in total assets and $0 in total liabilities. Its intangible assets were valued at $129.75 million while shareholder equity stood at $-8058896.00.

European Biotech Acquisition Corp ended 2024 with $0 in deferred long-term liabilities, $795568.00 in other current liabilities, in common stock, $-8059261.00 in retained earnings and $0 in goodwill. Its cash balance stood at $308488.00 and cash and short-term investments were $308488.00. The company’s total short-term debt was $0 while long-term debt stood at $0.

European Biotech Acquisition Corp’s total current assets stands at $356637.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $359537.00 and inventory worth $0.

In 2024, European Biotech Acquisition Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, European Biotech Acquisition Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.52
52-Week High
$0.7355
52-Week Low
$0.02
Analyst Target Price
$

European Biotech Acquisition Corp stock is currently trading at $0.52 per share. It touched a 52-week high of $0.7355 and a 52-week low of $0.7355. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.31 and 200-day moving average was $0.28 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About European Biotech Acquisition Corp

The stock symbol (also called stock or share ticker) of European Biotech Acquisition Corp is EBACW

The IPO of European Biotech Acquisition Corp took place on 2021-05-13

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

European Biotech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2021 and is based in Amsterdam, the Netherlands.

Address

Johannes Vermeerplein 9, Amsterdam, Netherlands, 1071 DV